AstraZeneca has paused a planned investment in the U.K., which had been set to create 1,000 jobs.

Drug companies increasingly frustrated with the Government over surging NHS clawbacks

Its decision comes as the industry says there is a lack of government investment and as the US pressures firms to invest there.

AstraZeneca has paused a planned investment in the U.K., which had been set to create 1,000 jobs.